Kathleen Scott - 03 Jan 2022 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
Director
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
Issuer symbol
DRMA
Transactions as of
03 Jan 2022
Transactions value $
$0
Form type
4
Filing time
05 Jan 2022, 18:05:36 UTC
Previous filing
17 Aug 2021
Next filing
08 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRMA Stock Option (right to buy) Award $0 +5,000 $0 5,000 03 Jan 2022 Common Stock 5,000 $1.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in twelve equal monthly installments commencing January 3, 2022.